|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 25, 2017 ) The report "Ablation Technologies Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Browse 76 market data tables and 43 figures spread through 197 pages and in-depth TOC on "Ablation Technologies Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021"
http://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html
Early buyers will receive 10% customization on reports.
This report studies the global ablation technologies market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.73 Billion by 2021, at a CAGR of 10.9% from 2016 to 2021.
A number of factors such as an increasing number of ablation procedures, growing prevalence of target diseases including cancer and cardiovascular diseases, the emergence of next-generation ablation products and technologies, increasing number of hospitals and ablation centers drive the growth of the market. On the other hand, factors such as reuse and reprocessing of devices in developing countries and healthcare cost-containment measures may restrict the growth of the market.
On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command the largest share of the market in 2016, due to lower cost of radiofrequency ablation procedures than other ablation techniques.
Based on product, the market is classified into seven major segments, namely, light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators. The light/laser ablators segment is further classified into excimer laser ablators and cold laser ablators. The radiofrequency ablators market is categorized into temperature-controlled RF ablators, fluid-cooled RF ablators, and robotic catheter manipulation systems. Similarly, the electrical ablators market is categorized into argon plasma/beam coagulators and irreversible electroporation ablators. The ultrasound ablators segment includes high-intensity focused ultrasound ablators, magnetic resonance-guided focused ultrasound ablators, ultrasonic surgical ablation systems, and extracorporeal shockwave lithotripsy systems. Similarly, the cryoablation devices segment is categorized into three subsegments, namely tissue contact probe ablators, tissue spray probe ablators, and epidermal & subcutaneous cryoablation systems. The microwave ablators segment is estimated to grow at the highest CAGR from 2016 to 2021 due to advantages offered by it over other ablation technologies.
By application, the market is categorized into cardiovascular disease, pain management, cancer, ophthalmology, cosmetic surgery, gynecology, urology, orthopedics, and others. The cardiovascular disease segment is estimated to account for the largest share of the global market in 2016 owing to the rising incidence of atrial fibrillation across the globe.
As of 2016, North America holds the largest share of the market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors including growing popularity of minimally invasive surgeries, government efforts to increase population access for elective surgeries, rising focus of global players, large population base and improving healthcare infrastructure in the region are stimulating the growth of the market in the Asia-Pacific region.
Medtronic plc (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan) are the major players in the market.
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
